Ah receptor signals cross-talk with multiple developmental pathways.

For many years, the Ah receptor (AHR) has been a favorite of toxicologists and molecular biologists studying the connections between genes and the changes in the control of gene expression resulting from environmental exposures. Much of the attention given to the Ah receptor has focused on the nature of its ligands, many of which are known or suspected carcinogens, and on the role that its best studied regulatory product, the CYP1A1 enzyme, plays in toxic responses and carcinogen activation. This understandable bias has resulted in a disproportionate amount of Ah receptor research being directed at toxicological or adaptive end points. In recent times, it has become evident that Ah receptor functions are also involved in molecular cascades that lead to inhibition of proliferation, promotion of differentiation, or apoptosis, with an important bearing in development. Developmental and toxicological AHR functions may not always be related. The ancestral AHR protein in invertebrates directs the developmental fate of a few specific neurons and does not bind xenobiotic ligands. The mammalian AHR maintains normal liver function in the absence of exogenous ligands and, when activated by dioxin, cross-talks with morphogenetic and developmental signals. Toxic end points, such as the induction of cleft palate by dioxin in mice embryos, might be at the crossroads of these signals and provide important clues as to the developmental role of the AHR.

[1]  J. Taipale,et al.  Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action. , 1999, Cytokine & growth factor reviews.

[2]  M. Gassmann,et al.  Oxygen-regulated expression of TGF-beta 3, a growth factor involved in trophoblast differentiation. , 2003, Placenta.

[3]  R. Ulrich,et al.  Identification of dioxin-responsive genes in Hep G2 cells using differential mRNA display RT-PCR. , 1996, Biochemical and biophysical research communications.

[4]  L. Birnbaum Developmental effects of dioxins. , 1995, Environmental health perspectives.

[5]  J. Craig,et al.  Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  M. Hind,et al.  Retinoic acid, a regeneration‐inducing molecule , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[7]  H. Swanson,et al.  The AH-receptor: genetics, structure and function. , 1993, Pharmacogenetics.

[8]  J. Goldstein,et al.  Mouse Liver CYP2C39 Is a Novel Retinoic Acid 4-Hydroxylase , 2004, Journal of Biological Chemistry.

[9]  A. Rizzino,et al.  Isolation and characterization of the murine transforming growth factor-β2 promoter , 2001 .

[10]  R. Tjian,et al.  Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. , 1988, Genes & development.

[11]  D. Nebert,et al.  Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. , 1990, Trends in genetics : TIG.

[12]  K. Gaido,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and -beta 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. , 1992, The Journal of biological chemistry.

[13]  W B Wood,et al.  Caenorhabditis elegans orthologs of the aryl hydrocarbon receptor and its heterodimerization partner the aryl hydrocarbon receptor nuclear translocator. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Nottoli,et al.  Transcription factor AP-2gamma is essential in the extra-embryonic lineages for early postimplantation development. , 2002, Development.

[15]  Hongtao Qin,et al.  The Caenorhabditis elegans aryl hydrocarbon receptor, AHR-1, regulates neuronal development. , 2004, Developmental biology.

[16]  C. Elferink,et al.  A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein , 1998, The Journal of Biological Chemistry.

[17]  A. Koff,et al.  p27Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells , 1999 .

[18]  K. Zuckerman,et al.  Cell Cycle and Transcriptional Control of Human Myeloid Leukemic Cells by Transforming Growth Factor Beta , 2000, Leukemia & lymphoma.

[19]  C. Tohyama,et al.  Role of estradiol receptor-alpha in differential expression of 2,3,7, 8-tetrachlorodibenzo-p-dioxin-inducible genes in the RL95-2 and KLE human endometrial cancer cell lines. , 1999, Archives of biochemistry and biophysics.

[20]  D. Spink,et al.  Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. , 2003, Biochemical pharmacology.

[21]  L. Stubbs,et al.  Deficiency of the β3 subunit of the type A γ–aminobutyric acid receptor causes cleft palate in mice , 1995, Nature Genetics.

[22]  Richard E Peterson,et al.  A ligand for the aryl hydrocarbon receptor isolated from lung , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Murray H. Brilliant,et al.  Mice devoid of γ-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior , 1997 .

[24]  Xiaoqing Chang,et al.  Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function. , 2002, Biochemical pharmacology.

[25]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[26]  T. Yagi,et al.  Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Capecchi,et al.  Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L S Birnbaum,et al.  A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism. , 1990, Teratology.

[29]  E. Hay,et al.  TGFβ3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development , 2003, The Journal of cell biology.

[30]  L. Stubbs,et al.  Concordance between isolated cleft palate in mice and alterations within a region including the gene encoding the beta 3 subunit of the type A gamma-aminobutyric acid receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Nau,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the endogenous metabolism of all-trans-retinoic acid in the rat , 2003, Archives of Toxicology.

[32]  S. Kliewer,et al.  Retinoic acid is a negative regulator of AP-1-responsive genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Gallo,et al.  Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity* , 1999, The Journal of Biological Chemistry.

[34]  M. Sporn,et al.  Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene , 1991, Molecular and cellular biology.

[35]  M. Sporn,et al.  Complex regulation of TGF beta expression by retinoic acid in the vitamin A-deficient rat. , 1991, Development.

[36]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[37]  Yishi Jin,et al.  The AHR-1 aryl hydrocarbon receptor and its co-factor the AHA-1 aryl hydrocarbon receptor nuclear translocator specify GABAergic neuron cell fate in C. elegans , 2004, Development.

[38]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[39]  D. Nebert,et al.  Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. , 2000, Biochemical pharmacology.

[40]  M. E. Hahn,et al.  Aryl hydrocarbon receptors: diversity and evolution. , 2002, Chemico-biological interactions.

[41]  O. Hankinson,et al.  Cloning of a factor required for activity of the Ah (dioxin) receptor. , 1991, Science.

[42]  A. D'Angelo,et al.  Decorin transfection in human mesangial cells downregulates genes playing a role in the progression of fibrosis , 2002, Journal of clinical laboratory analysis.

[43]  J. Reynolds,et al.  Developmental expression of functional GABAA receptors containing the gamma 2 subunit in neurons derived from embryonal carcinoma (P19) cells. , 1996, Brain research. Molecular brain research.

[44]  M. Ferguson,et al.  TGF-beta3 is required for the adhesion and intercalation of medial edge epithelial cells during palate fusion. , 2002, The International journal of developmental biology.

[45]  E. Madarász,et al.  Sequential induction of embryonic and adult forms of glutamic acid decarboxylase during in vitro‐induced neurogenesis in cloned neuroectodermal cell‐line, NE‐7C2 , 2002, Journal of neurochemistry.

[46]  R. Hynes,et al.  Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo , 1998, Cell.

[47]  P. Terranova,et al.  Alteration in ovarian gene expression in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin: reduction of cyclooxygenase-2 in the blockage of ovulation. , 2002, Reproductive toxicology.

[48]  A. Rizzino,et al.  Regulation of the transforming growth factor‐β2 gene promoter in embryonal carcinoma cells and their differentiated cells: Differential utilization of transcription factors , 1995 .

[49]  M. Sadar,et al.  Phenobarbital induction of cytochrome P4501A1 is regulated by cAMP-dependent protein kinase-mediated signaling pathways in rainbow trout hepatocytes. , 1996, Biochemical and biophysical research communications.

[50]  L. D. De Luca,et al.  Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. , 1997, Cancer research.

[51]  K. Gaido,et al.  The actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin on transforming growth factor-beta2 promoter activity are localized to the TATA box binding region and controlled through a tyrosine kinase-dependent pathway. , 1996, Toxicology and Applied Pharmacology.

[52]  T. Doetschman,et al.  Interpretation of phenotype in genetically engineered mice. , 1999, Laboratory animal science.

[53]  C. Carpenter,et al.  Evidence that GABAergic neurons in the preoptic area of the rat brain are targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin during development. , 2002, Environmental health perspectives.

[54]  L. Bjeldanes,et al.  Lipoxin A4: a new class of ligand for the Ah receptor. , 1999, Biochemistry.

[55]  C. Elferink,et al.  Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. , 2001, Molecular pharmacology.

[56]  P. Kondaiah,et al.  Differential expression of TGF beta isoforms in murine palatogenesis. , 1990, Development.

[57]  Mario Medvedovic,et al.  Expression of genes in the TGF-beta signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice. , 2004, Toxicology and applied pharmacology.

[58]  D. Morris,et al.  Role of TGF-β in RA-induced cleft palate in CD-1 mice , 1998 .

[59]  L. Birnbaum,et al.  Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. , 1994, Toxicology and applied pharmacology.

[60]  G. Morriss-Kay,et al.  Embryonic development and pattern formation , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  O. Hankinson The aryl hydrocarbon receptor complex. , 1995, Annual review of pharmacology and toxicology.

[62]  Matthew W. Strobeck,et al.  Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest , 2000, Oncogene.

[63]  M. Sporn,et al.  Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis. , 1989, Cell regulation.

[64]  M. Kretzschmar,et al.  Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1 , 1997, Nature.

[65]  O. Hankinson,et al.  Identification of a novel dioxin-inducible cytochrome P450. , 2002, Molecular pharmacology.

[66]  G. Perdew,et al.  A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins , 2002, Journal of biochemical and molecular toxicology.

[67]  R. Tjian,et al.  Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. , 1991, Genes & development.

[68]  M. Karsdal,et al.  Matrix Metalloproteinase-dependent Activation of Latent Transforming Growth Factor-β Controls the Conversion of Osteoblasts into Osteocytes by Blocking Osteoblast Apoptosis* , 2002, The Journal of Biological Chemistry.

[69]  A. Schecter Dioxins and Health , 2003, Springer US.

[70]  M. Ferguson,et al.  Transforming growth factor–β3 is required for secondary palate fusion , 1995, Nature Genetics.

[71]  K. Dold,et al.  Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. , 1991, Science.

[72]  K. Flanders,et al.  Interactions between retinoids and TGF beta s in mouse morphogenesis. , 1992, Development.

[73]  H. Rosenkranz,et al.  Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. , 1987, The Journal of biological chemistry.

[74]  M. Schmidt,et al.  Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. , 2001, American journal of respiratory and critical care medicine.

[75]  S. Kojima,et al.  Retinoids in liver fibrosis and cancer. , 2002, Frontiers in bioscience : a journal and virtual library.

[76]  M. Medvedovic,et al.  The transcriptional signature of dioxin in human hepatoma HepG2 cells. , 2000, Biochemical pharmacology.

[77]  A. Fornace,et al.  The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. , 1998, Molecular pharmacology.

[78]  A. Puga,et al.  Constitutive Activation of the Aromatic Hydrocarbon Receptor , 1998, Molecular and Cellular Biology.

[79]  A. McMahon,et al.  Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2 , 1996, Nature.

[80]  D. Phelan,et al.  Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. , 1998, Archives of biochemistry and biophysics.

[81]  G. Morriss-Kay Craniofacial defects in AP-2 null mutant mice. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[82]  A. Morrow,et al.  GABAA Receptors Mediate Trophic Effects of GABA on Embryonic Brainstem Monoamine Neurons In Vitro , 1997, The Journal of Neuroscience.

[83]  Cis‐regulatory elements and transcription factors involved in the regulation of the transforming growth factor‐β2 gene , 1995, Molecular reproduction and development.

[84]  Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240 , 2002 .

[85]  M. Sporn,et al.  Regulation of the transforming growth factor-β1 and -β3 promoters by transcription factor Spl , 1993 .

[86]  J. Mansell,et al.  Microarray analysis of murine palatogenesis: Temporal expression of genes during normal palate development , 2003, Development, growth & differentiation.

[87]  K. Okamoto,et al.  A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells , 1990, Cell.

[88]  M. Sporn,et al.  Regulation of transforming growth factor-β subtypes by members of the steroid hormone superfamily , 1990, Journal of Cell Science.

[89]  Garet P Lahvis,et al.  Resistance to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicity and Abnormal Liver Development in Mice Carrying a Mutation in the Nuclear Localization Sequence of the Aryl Hydrocarbon Receptor* , 2003, The Journal of Biological Chemistry.

[90]  A. Fornace,et al.  Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. , 2000, Molecular pharmacology.

[91]  K. Gaido,et al.  Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1994, Toxicology and applied pharmacology.

[92]  W. F. Greenlee,et al.  Classification of members of the Ah gene battery , 1992 .

[93]  E. Knudsen,et al.  The Aryl Hydrocarbon Receptor Displaces p300 from E2F-dependent Promoters and Represses S Phase-specific Gene Expression* , 2004, Journal of Biological Chemistry.

[94]  E. Knudsen,et al.  Aromatic Hydrocarbon Receptor Interaction with the Retinoblastoma Protein Potentiates Repression of E2F-dependent Transcription and Cell Cycle Arrest* , 2000, The Journal of Biological Chemistry.

[95]  R. Jaenisch,et al.  Transcription factor AP-2 essential for cranial closure and craniofacial development , 1996, Nature.

[96]  D. Calvisi,et al.  Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion , 2004, Hepatology.

[97]  J. Whitlock,et al.  Mechanistic aspects of dioxin action. , 1993, Chemical research in toxicology.

[98]  A. Schecter,et al.  Exposure Assessment: Measurement of Dioxins and Related Chemicals in Human Tissues , 2005 .

[99]  M. Sporn,et al.  Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. , 1989, The Journal of biological chemistry.

[100]  Gillian Smith,et al.  Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases , 2003, The Lancet.

[101]  S. Mulero-Navarro,et al.  Overexpression of latent transforming growth factor-β binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts , 2004, Journal of Cell Science.

[102]  D. Lawrence Latent-TGF-β: An overview , 2001, Molecular and Cellular Biochemistry.

[103]  C. Shuler,et al.  Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects , 2003, Development.

[104]  A. Morrow,et al.  GABA as a trophic factor for developing monoamine neurons. , 1998, Perspectives on developmental neurobiology.

[105]  K. Renskers,et al.  Diazepam-induced cleft palate in the mouse and lack of correlation with the H-2 locus. , 1987, Teratology.

[106]  R. Tjian,et al.  Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. , 1989, Genes & development.

[107]  Mario Medvedovic,et al.  Different global gene expression profiles in benzo[a]pyrene-and dioxin-treated vascular smooth muscle cells of AHR-knockout and wild-type mice , 2007, Cardiovascular Toxicology.

[108]  V. Kaartinen,et al.  Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction , 1995, Nature Genetics.

[109]  C. Bradfield,et al.  Patent Ductus Venosus and Dioxin Resistance in Mice Harboring a Hypomorphic Arnt Allele* , 2004, Journal of Biological Chemistry.

[110]  A. Tobin,et al.  Multiple elements regulate GAD65 transcription. , 1997, Developmental neuroscience.

[111]  M. Sporn,et al.  Differential regulation of the expression of transforming growth factor‐β mRNAs by growth factors and retinoic acid in chicken embryo chondrocytes, myocytes, and fibroblasts , 1992, Journal of cellular physiology.

[112]  M. Ferguson,et al.  TGF-beta(3)-induced chondroitin sulphate proteoglycan mediates palatal shelf adhesion. , 2002, Developmental biology.

[113]  T Matsumoto,et al.  Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.